Simon A Mallal Selected Research

Simon A Mallal Research Topics

Disease

9	Hypersensitivity (Allergy) 01/2022 - 06/2005
8	Infections 01/2022 - 10/2005
5	Drug-Related Side Effects and Adverse Reactions 01/2019 - 02/2008
4	HIV Infections (HIV Infection) 01/2019 - 02/2003
3	Drug Hypersensitivity Syndrome 01/2019 - 03/2011
3	Stevens-Johnson Syndrome (Lyell's Syndrome) 03/2011 - 06/2009
2	Viremia 01/2022 - 11/2017
2	Tuberculosis (Tuberculoses) 12/2021 - 01/2021
2	Triple Negative Breast Neoplasms 02/2019 - 03/2016
2	Neoplasms (Cancer) 01/2019 - 03/2016
2	Drug Hypersensitivity (Drug Allergy) 07/2010 - 06/2009
1	Atherosclerosis 01/2022
1	Persistent Infection 02/2021
1	Metaplasia 12/2020
1	Hyperplasia 12/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Vasculitis (Vasculitides) 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Eosinophilia 01/2019
1	Encephalitis (Encephalitis, Rasmussen) 01/2019
1	Severe Dengue 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2019
1	Obesity 11/2018
1	Vascular Diseases (Vascular Disease) 11/2017
1	Virus Diseases (Viral Diseases) 11/2017
1	Herpes Genitalis (Genital Herpes) 12/2016
1	Hypertension (High Blood Pressure) 04/2016
1	Breast Neoplasms (Breast Cancer) 03/2016
1	Asthma (Bronchial Asthma) 01/2016
1	Peanut Hypersensitivity (Peanut Allergy) 12/2015
1	Chemical and Drug Induced Liver Injury 01/2013
1	Chronic Hepatitis B 01/2012
1	Chronic Disease (Chronic Diseases) 11/2005
1	Cushing Syndrome 04/2005
1	Acute-Phase Reaction 07/2004

Drug/Important Bio-Agent (IBA)

9	abacavir (Ziagen)FDA Link 01/2022 - 06/2005
7	EpitopesIBA 01/2020 - 07/2004
5	VaccinesIBA 12/2021 - 10/2005
5	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 01/2012
5	HLA-B Antigens (HLA-B)IBA 01/2013 - 02/2008
4	AntigensIBA 02/2021 - 02/2008
4	Pharmaceutical PreparationsIBA 11/2017 - 02/2008
3	HLA-B57 antigenIBA 01/2022 - 01/2018
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2021 - 11/2018
2	CytokinesIBA 01/2022 - 01/2016
2	Interleukin-5 (Interleukin 5)IBA 12/2020 - 01/2016
2	Interleukin-13IBA 12/2020 - 01/2016
2	Immune Checkpoint InhibitorsIBA 02/2019 - 03/2016
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2019 - 03/2016
2	Vancomycin FDA LinkGeneric 01/2019 - 01/2019
2	HLA-A Antigens (HLA-A)IBA 01/2019 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 12/2016 - 06/2009
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2012 - 10/2005
2	Allopurinol (Remid)FDA LinkGeneric 03/2011 - 06/2009
1	efavirenz (Sustiva)FDA Link 01/2022
1	Emtricitabine (Emtriva)FDA Link 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Viral ProteinsIBA 02/2021
1	spasmolytic polypeptideIBA 12/2020
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2020
1	Peroxidase (Myeloperoxidase)IBA 01/2020
1	Biological ProductsIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	tau Proteins (tau Protein)IBA 01/2019
1	A 19IBA 01/2019
1	isolevuglandinIBA 11/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Glycoproteins (Glycoprotein)IBA 11/2017
1	HLA-DR7 Antigen (HLA DR7 Antigen)IBA 11/2017
1	Interleukin-17 (Interleukin 17)IBA 04/2016
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 04/2016
1	SaltsIBA 04/2016
1	Angiotensin IIIBA 04/2016
1	InterferonsIBA 04/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	ProstaglandinsIBA 01/2016
1	HLA-DR Antigens (HLA-DR)IBA 12/2015
1	HLA-DQ Antigens (HLA-DQ)IBA 12/2015
1	HLA-DRB1 Chains (HLA DRB1)IBA 12/2015
1	Floxacillin (Flucloxacillin)IBA 01/2013
1	Hepatitis B e AntigensIBA 01/2012
1	Anticonvulsants (Antiepileptic Drugs)IBA 03/2011
1	AminesIBA 03/2011
1	Carbamazepine (Tegretol)FDA LinkGeneric 06/2009
1	Nevirapine (Viramune)FDA Link 02/2008
1	Interferon-gamma (Interferon, gamma)IBA 10/2005
1	Ritonavir (Norvir)FDA Link 04/2005
1	Fluticasone (Cutivate)FDA LinkGeneric 04/2005
1	HLA-A3 Antigen (HLA A3 Antigen)IBA 07/2004
1	RNA (Ribonucleic Acid)IBA 02/2003

Therapy/Procedure

5	Therapeutics 01/2020 - 02/2003
1	Neoadjuvant Therapy 03/2016
1	Immunotherapy 03/2016